Sequence LifeScience Inc Receives IRB Approval for Novel Matched Controls Clinical Trial Targeting Diabetic Foot Ulcers
Chronic wound study leverages past data to reduce control groups, improve healing outcomes, and fast-track promising therapies to patients. SAN ANTONIO, TX, UNITED STATES, August 7, 2025 /EINPresswire.com/ -- Groundbreaking study aims to improve healing …